Nyxoah SA (NASDAQ:NYXH) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 5:35 PM EDT
Company Participants
Olivier Taelman – CEO & Executive Director
Presentation
Unknown Analyst
Excellent. Thank you, everyone, for joining us. Before we begin, I’ll give the standard disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that, thanks, everyone, for joining us. We are here with the CEO of Nyxoah. Thanks for being with us here, Olivier.
Olivier Taelman
CEO & Executive Director
Yes. So first of all, thank you for having us and giving us the opportunity to interact and meet with investors, highly appreciate it.
Question-and-Answer Session
Unknown Analyst
Yes, absolutely. So maybe to kick it off, for those in the audience unfamiliar with Nyxoah, could you please provide a brief overview of how Nyxoah is changing the obstructive sleep apnea landscape?
Olivier Taelman
CEO & Executive Director
Yes. No, no, definitely. So with Nyxoah, we are offering an innovative next-generation neuromodulation solution, more specific hypoglossal nerve stimulation to treat moderate-to-severe OSA patients. I do think we can say we have a totally differentiated technology driven by bilateral stimulation, single-incision implant.
Next to the bilateral stimulation and single incision, it’s also clear that we go with full body MRI compatibility from the beginning for the simple reason that we do not have an implantable battery. When we look at the wearable component, so the piece that the patient will wear when he’s or she is sleeping, the wearable component is containing the battery, but also the software of the system. And one of the big advantages when you do not have an implantable battery is that there is no need for resurgery when the battery is depleted, but there
#Nyxoah #NYXH #Morgan #Stanley #23rd #Annual #Global #Healthcare #Conference #Transcript